Digestive Health Associates of Texas

What Digestive Health Associates of Texas does

Digestive Health Associates of Texas (DHAT) is a physician-led gastroenterology network serving patients across the Dallas-Fort Worth metroplex. Founded in 1996 and operating as a private professional corporation, the practice offers a comprehensive portfolio of gastrointestinal and liver services spanning diagnostic procedures (colonoscopy, EGD, ERCP, enteroscopy, flexible sigmoidoscopy, FibroScan transient elastography, SmartPill wireless capsule motility testing, high-resolution esophageal and anorectal manometry), therapeutic procedures (EMR, POEM, TIF, hemorrhoid banding, argon laser therapy, sphincterotomy, PEG feeding tube insertion, esophageal dilation), infusion therapy for IBD and autoimmune conditions (Remicade, Entyvio, Stelara and biosimilars), pediatric gastroenterology, and telehealth (TeleVisits via Doxy.me). The practice also operates the wholly-owned DHAT Research Institute, conducting Phase 1-4 clinical trials with emphasis on Phase 2 and Phase 3 across Crohn's disease, ulcerative colitis, IBS, celiac, GERD, NASH, and hepatitis indications.

DHAT operates as a subsidiary within GI Alliance, the largest Patient-Focused, Physician-Led Gastroenterology practice in the United States, having joined the platform in 2020. Under this structure, DHAT retains physician-led clinical governance while gaining access to centralized resources, clinical trial pipelines, and broader referral networks. Patient acquisition is sales-led but primarily patient- and referral-driven (primary care physicians and self-referred consumers searching for GI providers), supported by an SEO-oriented website with provider/location finders, a patient portal (ModMed/Modernizing Medicine), and condition-specific educational content. Telemedicine functions as a non-physical delivery channel layered on top of the multi-clinic physical footprint spanning North Richland Hills to McKinney.

The revenue model is professional services billing across clinical procedures, infusion therapy administration, and clinical trial participation. Pricing is not publicly disclosed; insurance coverage varies by payer and procedure, and patients are directed to contact individual locations for cost information. DHAT serves both adult and pediatric patient segments across the DFW metroplex, with primary care physicians as a secondary referring segment. The company has 101-250 employees and operates multiple physical clinic locations; no public revenue figures, funding history, or M&A activity beyond the 2020 GI Alliance integration have been disclosed.

Name

Digestive Health Associates of Texas

Legal name

Digestive Health Associates of Texas, P.A.

Website

https://dhat.com

Company type

Private

Founded year

1996

Operating status

Operating

Headcount range

101–250 employees

Short description

Digestive Health Associates of Texas is a physician-led gastroenterology network serving adult and pediatric patients across the Dallas-Fort Worth metroplex with diagnostic, therapeutic, infusion, and clinical research services, operating as a subsidiary of GI Alliance since 2020.

Ownership category

akta.pro rank

Product category

Gastroenterology Services

NAICS

Ambulatory Health Care Services (621), Medical and Diagnostic Laboratories (6215)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

General Gastroenterology (HLAKAEAA)

akta.pro secondary industries

Outpatient Endoscopy & GI Procedure Centers (Non-ASC) (HLAFABAL), Pediatric Gastroenterology & Hepatology (HLAKAEAH), Liver & GI Clinical Research (Trials Centers) (HLAKAEAL), Endoscopy & GI Diagnostic Centers (HLAFAKAG)

Keywords

• Gastroenterology services
• Endoscopic procedures
• Colon cancer screening
• Infusion therapy
• Pediatric gastroenterology

Headquarters

HQ city

Dallas

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Clinical GI Services: Revenue generated from diagnostic and therapeutic gastroenterology procedures including colonoscopies, endoscopies, ERCP, and various treatments for GI conditions
2. Infusion Therapy Services: IV infusion therapy administration for inflammatory bowel diseases and autoimmune disorders, including biologics like Remicade, Entyvio, Stelara, and biosimilars
3. Clinical Research Trials: DHAT Research Institute participates in clinical trials across all phases, providing patients access to cutting-edge treatments before FDA approval

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Digestive Health Associates of Texas is a physician-led gastroenterology network delivering diagnostic and therapeutic GI services across the Dallas-Fort Worth metroplex. Core offerings include colon cancer screening and colonoscopy, advanced endoscopic procedures (ERCP, EGD, EMR, POEM, TIF, enteroscopy), FibroScan liver assessment, SmartPill motility testing, high-resolution manometry, infusion therapy for inflammatory bowel disease, hemorrhoid banding, and pediatric gastroenterology. The practice also operates the DHAT Research Institute for clinical trials and provides telemedicine consultations via Doxy.me.

Product overview

Digestive Health Associates of Texas is a physician-led gastroenterology network serving the Dallas-Fort Worth area, offering comprehensive digestive health services for adults and children. The practice provides a broad portfolio of diagnostic and therapeutic medical procedures including endoscopic examinations (colonoscopy, EGD, ERCP, enteroscopy), advanced imaging technologies (FibroScan for liver assessment, high-resolution manometry tests), minimally invasive procedures (argon laser therapy, EMR, POEM, TIF, hemorrhoid banding), and infusion therapy for inflammatory conditions. The network also operates the DHAT Research Institute for clinical trials and offers pediatric gastroenterology services and virtual telemedicine consultations. The practice became part of GI Alliance in 2020.

Differentiator

Problem solved

Functional benefit

Products and services

• Colonoscopy Diagnostic procedure using a flexible scope with camera to examine the entire colon. Serves as the primary preventive measure for colorectal cancer by enabling polyp removal.
• Colon Cancer Screening Screening services to identify polyps and cancerous growths in the colon and rectum before symptoms manifest. Includes colonoscopy, virtual colonoscopy, fecal tests, and flexible sigmoidoscopy options.
• Upper GI Endoscopy (EGD) Esophagogastroduodenoscopy procedure using a scope through the mouth to examine the esophagus, stomach, and duodenum for diagnosing GI problems.
• Endoscopic Retrograde Cholangiopancreatography (ERCP) Endoscopic procedure for diagnosing and treating diseases of the bile duct, pancreatic duct, and gallbladder including gallstone removal and stent placement.
• Endoscopic Mucosal Resection (EMR) Outpatient procedure to remove tumors below the GI lining without surgery using an endoscope. Allows removal of upper GI or colon polyps that might otherwise require an operation.
• Peroral Endoscopic Myotomy (POEM) Minimally invasive procedure for achalasia that involves making an incision in the inner layer of the esophagus through the mouth to weaken the lower esophageal sphincter.
• Transoral Incisionless Fundoplication (TIF) Minimally invasive surgical procedure for GERD that manipulates the fundus and esophagus through the mouth to enhance function at the gastroesophageal junction without incisions.
• Enteroscopy Endoscopic procedure using an extended scope inserted through the mouth to examine the jejunum (second portion of the small intestine) for diagnosing causes of abdominal pain, bleeding, or abnormal x-ray results.
• Flexible Sigmoidoscopy Endoscopic examination of the rectum and lower third of the colon using a flexible scope to diagnose GI symptoms and screen for colon cancer.
• Argon Laser Therapy Laser-based treatment using argon gas technology to treat gastrointestinal conditions including dysphagia, mucosal lesions, hemorrhages, and strictures. Provides greater precision than traditional surgery with shallower incisions and less tissue trauma.
• Esophageal Dilation Endoscopic procedure using balloon dilation to expand narrowed sections of the esophagus (strictures) to relieve swallowing difficulties.
• Feeding Tube Insertion (PEG) Percutaneous endoscopic gastrostomy procedure to insert a feeding tube directly into the stomach for patients unable to consume adequate nutrition orally.
• Hemorrhoid Banding Rubber band ligation procedure to remove internal hemorrhoids by discontinuing blood flow to the hemorrhoid, causing it to shrink and fall off.
• Sphincterotomy Surgical procedure (lateral internal sphincterotomy) to treat chronic anal fissures by creating an incision in the internal anal sphincter to reduce pressure and allow healing.
• FibroScan Noninvasive liver examination using transient elastography (specialized ultrasound technology) to measure liver fibrosis and hepatic steatosis without invasive biopsy.
• Wireless Capsule Motility Testing (SmartPill) Ingestible capsule (SmartPill) that monitors pH, pressure, transit time, and temperature throughout the entire GI tract to evaluate motility disorders.
• High-Resolution Esophageal Manometry Assessment procedure to evaluate the contractile function of the esophagus, diagnosing conditions like esophageal spasm, chest pain, GERD, and difficulty swallowing.
• High-Resolution Anorectal Manometry Diagnostic test evaluating the responses and strength of muscles required for normal bowel movements, performed on patients with constipation or fecal incontinence.
• Infusion Therapy (IV Infusion) Intravenous administration of biologic medications for inflammatory bowel diseases (Crohn's disease, ulcerative colitis) and other autoimmune disorders. Includes medications such as Infliximab, REMICADE, ENTYVIO, STELARA, and iron products.
• Pediatric Gastroenterology Assessment and management of GI-related issues in children from birth to 18 years, including diagnostic testing, treatment plans, and procedures tailored for pediatric patients.
• Virtual Telemedicine (TeleVisits) Remote video consultation service enabling patients to connect with doctors via smartphone or computer for continuity of care without in-person visits, using Doxy.me.
• DHAT Research Institute Clinical research division conducting Phase 1–4 trials focusing on Phase 2 and Phase 3, providing access to cutting-edge treatments before FDA approval. Conditions studied include Crohn's disease, ulcerative colitis, IBS, celiac disease, GERD, NASH, hepatitis, and others.

Quantifiable outcome

• Colonoscopy is the only preventive measure for colorectal cancer when started at age 45

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature3 records

Partnerships

One partnership is on record.

• GI AlliancecoreStrategic or Co-development Partner · 1 January 2020In 2020, DHAT became part of GI Alliance, described as the largest Patient-Focused, Physician-Led Gastroenterology practice in the United States. This partnership allows DHAT patients access to more cutting-edge services, clinical trials, and resources. The cultures of both organizations aligned with like-minded physicians that have a patient-first attitude.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Texas Digestive Disease Consultants (TDDC): TDDC is a large multi-location gastroenterology group based in the Dallas-Fort Worth area and a fellow GI Alliance member. It is the most directly comparable peer to DHAT: similar specialty, similar scale, same regional market, and same parent platform.
• Austin Gastroenterology: Austin Gastroenterology is one of the largest independent GI specialty groups in Texas. Comparable to DHAT in that both deliver comprehensive adult and pediatric gastroenterology, infusion therapy, and clinical research across multiple locations in a Texas metropolitan market.
• Illinois Gastroenterology Group (IGG): IGG is a large multi-site gastroenterology practice and a GI Alliance member. Comparable to DHAT as a similarly scaled GI specialty group with the same parent platform, advanced procedures, and research participation.
• One GI: One GI is a PE-backed gastroenterology platform operating multi-physician GI practices across the Mid-South and Midwest. Comparable to DHAT as a multi-site GI specialty group of similar scale with a shared-platform, multi-state growth model.
• US Digestive Health: US Digestive Health is a private equity-backed network of GI practices in the Mid-Atlantic. Comparable to DHAT in scale, multi-location specialty GI model, infusion and ancillary services, and reliance on advanced endoscopic procedures.
• Gastroenterology Associates of Central Florida: A large multi-physician gastroenterology group serving central Florida. Comparable to DHAT as a multi-site GI specialty practice offering advanced procedures, infusion therapy, and clinical research with a similar regional concentration.
• Asheville Gastroenterology Associates: A GI Alliance-affiliated gastroenterology practice in North Carolina. Comparable to DHAT as a multi-physician GI specialty group with a similar scope of diagnostic, therapeutic, and infusion services under the same parent platform.

Broad incumbents

• Cleveland Clinic — Digestive Disease Institute: Cleveland Clinic operates a major academic gastroenterology and hepatology program serving patients across the US. Comparable to DHAT as a destination for complex GI care, but on a much broader institutional scale with overlapping advanced procedures and research portfolio.
• Mayo Clinic — Division of Gastroenterology & Hepatology: Mayo Clinic runs a nationally recognized gastroenterology and hepatology practice with deep clinical trial activity. Comparable to DHAT in offering advanced endoscopic procedures and research, but at academic-medical-center scale with much broader institutional scope.
• HCA Healthcare — Digestive Health Service Line: HCA operates hospital-based and employed-physician gastroenterology services across multiple states. Comparable to DHAT as a competing delivery channel for GI procedural volume, particularly through hospital outpatient departments and ASCs in the DFW and broader Texas markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/dhatTX

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Digestive Health Associates of Texas